Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
113.8 EUR | +1.34% | +7.06% | +5.47% |
Apr. 24 | IPSEN : Better-than-expected Q1; guidance unchanged | |
Apr. 24 | Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.47% | 9.91B | |
+25.61% | 660B | |
+24.24% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.45% | 219B | |
-9.65% | 196B | |
+6.52% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- IPN Stock
- News Ipsen
- Ipsen : Wins EMA's Positive Opinion for Cabometyx With Opdivo in Kidney Cancer Treatment